Cancer remains a priority for the Government, and we spend £1.5 billion on health and care research through the National Institute for Health and Care Research (NIHR) each year. Cancer is our biggest area of spend, and in 2022/23 the NIHR spent over £121.8 million on cancer research. This includes significant research on breast cancer risk, screening, and early detection and diagnosis. While we have not funded research looking into a link between Bisphenol A and breast cancer, we welcome high quality research proposals into any aspect of health and care, including potential cancer risks.